ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
JUN
|
ENSG00000177606.5 | JUN |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
JUN | hg19_v2_chr1_-_59249732_59249785 | 0.79 | 2.7e-04 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_54281407 | 5.66 |
ENST00000381403.4 |
ESM1 |
endothelial cell-specific molecule 1 |
chr6_+_139456226 | 5.42 |
ENST00000367658.2 |
HECA |
headcase homolog (Drosophila) |
chr11_+_117070037 | 4.47 |
ENST00000392951.4 ENST00000525531.1 ENST00000278968.6 |
TAGLN |
transgelin |
chr2_-_216300784 | 4.47 |
ENST00000421182.1 ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1 |
fibronectin 1 |
chr17_-_76899275 | 4.30 |
ENST00000322630.2 ENST00000586713.1 |
DDC8 |
Protein DDC8 homolog |
chrX_-_101771645 | 4.26 |
ENST00000289373.4 |
TMSB15A |
thymosin beta 15a |
chr3_+_62304712 | 4.09 |
ENST00000494481.1 |
C3orf14 |
chromosome 3 open reading frame 14 |
chr22_+_38597889 | 4.07 |
ENST00000338483.2 ENST00000538320.1 ENST00000538999.1 ENST00000441709.1 |
MAFF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
chr3_+_62304648 | 3.86 |
ENST00000462069.1 ENST00000232519.5 ENST00000465142.1 |
C3orf14 |
chromosome 3 open reading frame 14 |
chr3_+_158991025 | 3.86 |
ENST00000337808.6 |
IQCJ-SCHIP1 |
IQCJ-SCHIP1 readthrough |
chr2_-_216257849 | 3.73 |
ENST00000456923.1 |
FN1 |
fibronectin 1 |
chr6_+_121756809 | 3.65 |
ENST00000282561.3 |
GJA1 |
gap junction protein, alpha 1, 43kDa |
chr3_-_99594948 | 3.60 |
ENST00000471562.1 ENST00000495625.2 |
FILIP1L |
filamin A interacting protein 1-like |
chr11_+_12696102 | 3.58 |
ENST00000527636.1 ENST00000527376.1 |
TEAD1 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
chr8_-_42065187 | 3.57 |
ENST00000270189.6 ENST00000352041.3 ENST00000220809.4 |
PLAT |
plasminogen activator, tissue |
chr3_-_99595037 | 3.51 |
ENST00000383694.2 |
FILIP1L |
filamin A interacting protein 1-like |
chr9_+_116298778 | 3.41 |
ENST00000462143.1 |
RGS3 |
regulator of G-protein signaling 3 |
chr6_-_112575912 | 3.37 |
ENST00000522006.1 ENST00000230538.7 ENST00000519932.1 |
LAMA4 |
laminin, alpha 4 |
chr12_+_75874984 | 3.34 |
ENST00000550491.1 |
GLIPR1 |
GLI pathogenesis-related 1 |
chr3_+_159570722 | 3.31 |
ENST00000482804.1 |
SCHIP1 |
schwannomin interacting protein 1 |
chr2_-_190044480 | 3.26 |
ENST00000374866.3 |
COL5A2 |
collagen, type V, alpha 2 |
chr5_-_111312622 | 3.22 |
ENST00000395634.3 |
NREP |
neuronal regeneration related protein |
chr8_-_42065075 | 3.06 |
ENST00000429089.2 ENST00000519510.1 ENST00000429710.2 ENST00000524009.1 |
PLAT |
plasminogen activator, tissue |
chr11_+_12695944 | 3.03 |
ENST00000361905.4 |
TEAD1 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
chr12_+_75874580 | 2.93 |
ENST00000456650.3 |
GLIPR1 |
GLI pathogenesis-related 1 |
chr2_-_238322770 | 2.80 |
ENST00000472056.1 |
COL6A3 |
collagen, type VI, alpha 3 |
chr11_-_104817919 | 2.80 |
ENST00000533252.1 |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
chr5_-_54281491 | 2.74 |
ENST00000381405.4 |
ESM1 |
endothelial cell-specific molecule 1 |
chr2_-_238322800 | 2.73 |
ENST00000392004.3 ENST00000433762.1 ENST00000347401.3 ENST00000353578.4 ENST00000346358.4 ENST00000392003.2 |
COL6A3 |
collagen, type VI, alpha 3 |
chr2_-_238323007 | 2.67 |
ENST00000295550.4 |
COL6A3 |
collagen, type VI, alpha 3 |
chr6_+_89791507 | 2.65 |
ENST00000354922.3 |
PNRC1 |
proline-rich nuclear receptor coactivator 1 |
chr4_-_186456766 | 2.60 |
ENST00000284771.6 |
PDLIM3 |
PDZ and LIM domain 3 |
chr4_-_186456652 | 2.56 |
ENST00000284767.5 ENST00000284770.5 |
PDLIM3 |
PDZ and LIM domain 3 |
chr7_-_129592471 | 2.50 |
ENST00000473814.2 ENST00000490974.1 |
UBE2H |
ubiquitin-conjugating enzyme E2H |
chr6_-_112575838 | 2.44 |
ENST00000455073.1 |
LAMA4 |
laminin, alpha 4 |
chr9_-_99381660 | 2.41 |
ENST00000375240.3 ENST00000463569.1 |
CDC14B |
cell division cycle 14B |
chr7_-_129592700 | 2.35 |
ENST00000472396.1 ENST00000355621.3 |
UBE2H |
ubiquitin-conjugating enzyme E2H |
chr9_+_97488939 | 2.32 |
ENST00000277198.2 ENST00000297979.5 |
C9orf3 |
chromosome 9 open reading frame 3 |
chr16_+_3068393 | 2.28 |
ENST00000573001.1 |
TNFRSF12A |
tumor necrosis factor receptor superfamily, member 12A |
chr8_+_79428539 | 2.27 |
ENST00000352966.5 |
PKIA |
protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
chr10_+_123923105 | 2.25 |
ENST00000368999.1 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr5_+_71403061 | 2.21 |
ENST00000512974.1 ENST00000296755.7 |
MAP1B |
microtubule-associated protein 1B |
chr12_+_10365404 | 2.21 |
ENST00000266458.5 ENST00000421801.2 ENST00000544284.1 ENST00000545047.1 ENST00000543602.1 ENST00000545887.1 |
GABARAPL1 |
GABA(A) receptor-associated protein like 1 |
chr19_+_16186903 | 2.11 |
ENST00000588507.1 |
TPM4 |
tropomyosin 4 |
chr5_-_139944196 | 2.10 |
ENST00000357560.4 |
APBB3 |
amyloid beta (A4) precursor protein-binding, family B, member 3 |
chr18_-_5540471 | 2.10 |
ENST00000581833.1 ENST00000544123.1 ENST00000342933.3 ENST00000400111.3 ENST00000585142.1 |
EPB41L3 |
erythrocyte membrane protein band 4.1-like 3 |
chr19_+_16187085 | 2.08 |
ENST00000300933.4 |
TPM4 |
tropomyosin 4 |
chr8_-_125740730 | 1.96 |
ENST00000354184.4 |
MTSS1 |
metastasis suppressor 1 |
chr17_-_63822563 | 1.96 |
ENST00000317442.8 |
CEP112 |
centrosomal protein 112kDa |
chr5_-_172198190 | 1.96 |
ENST00000239223.3 |
DUSP1 |
dual specificity phosphatase 1 |
chr16_+_3115298 | 1.94 |
ENST00000325568.5 ENST00000534507.1 |
IL32 |
interleukin 32 |
chr2_+_37571717 | 1.93 |
ENST00000338415.3 ENST00000404976.1 |
QPCT |
glutaminyl-peptide cyclotransferase |
chr2_+_37571845 | 1.91 |
ENST00000537448.1 |
QPCT |
glutaminyl-peptide cyclotransferase |
chr4_-_7873981 | 1.90 |
ENST00000360265.4 |
AFAP1 |
actin filament associated protein 1 |
chr16_+_3115611 | 1.88 |
ENST00000530890.1 ENST00000444393.3 ENST00000533097.2 ENST00000008180.9 ENST00000396890.2 ENST00000525228.1 ENST00000548652.1 ENST00000525377.2 ENST00000530538.2 ENST00000549213.1 ENST00000552936.1 ENST00000548476.1 ENST00000552664.1 ENST00000552356.1 ENST00000551513.1 ENST00000382213.3 ENST00000548246.1 |
IL32 |
interleukin 32 |
chr10_+_123922941 | 1.88 |
ENST00000360561.3 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr11_-_89224488 | 1.86 |
ENST00000534731.1 ENST00000527626.1 |
NOX4 |
NADPH oxidase 4 |
chr1_+_28099683 | 1.82 |
ENST00000373943.4 |
STX12 |
syntaxin 12 |
chr11_-_89224299 | 1.81 |
ENST00000343727.5 ENST00000531342.1 ENST00000375979.3 |
NOX4 |
NADPH oxidase 4 |
chr6_-_56819385 | 1.79 |
ENST00000370754.5 ENST00000449297.2 |
DST |
dystonin |
chr16_+_3115323 | 1.79 |
ENST00000531965.1 ENST00000396887.3 ENST00000529699.1 ENST00000526464.2 ENST00000440815.3 |
IL32 |
interleukin 32 |
chr10_+_123923205 | 1.78 |
ENST00000369004.3 ENST00000260733.3 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr5_-_16916624 | 1.78 |
ENST00000513882.1 |
MYO10 |
myosin X |
chr1_-_59249732 | 1.74 |
ENST00000371222.2 |
JUN |
jun proto-oncogene |
chr6_-_112575758 | 1.73 |
ENST00000431543.2 ENST00000453937.2 ENST00000368638.4 ENST00000389463.4 |
LAMA4 |
laminin, alpha 4 |
chr3_-_114343768 | 1.73 |
ENST00000393785.2 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
chr11_-_63381925 | 1.72 |
ENST00000415826.1 |
PLA2G16 |
phospholipase A2, group XVI |
chr16_+_3115378 | 1.71 |
ENST00000529550.1 ENST00000551122.1 ENST00000525643.2 ENST00000548807.1 ENST00000528163.2 |
IL32 |
interleukin 32 |
chr9_-_99382065 | 1.70 |
ENST00000265659.2 ENST00000375241.1 ENST00000375236.1 |
CDC14B |
cell division cycle 14B |
chr1_+_25071848 | 1.68 |
ENST00000374379.4 |
CLIC4 |
chloride intracellular channel 4 |
chr3_-_124774802 | 1.67 |
ENST00000311127.4 |
HEG1 |
heart development protein with EGF-like domains 1 |
chr19_+_42772659 | 1.67 |
ENST00000572681.2 |
CIC |
capicua transcriptional repressor |
chr3_+_8543393 | 1.66 |
ENST00000157600.3 ENST00000415597.1 ENST00000535732.1 |
LMCD1 |
LIM and cysteine-rich domains 1 |
chr11_-_89224139 | 1.66 |
ENST00000413594.2 |
NOX4 |
NADPH oxidase 4 |
chr8_+_40010989 | 1.63 |
ENST00000315792.3 |
C8orf4 |
chromosome 8 open reading frame 4 |
chr10_+_124134201 | 1.61 |
ENST00000368990.3 ENST00000368988.1 ENST00000368989.2 ENST00000463663.2 |
PLEKHA1 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
chr1_-_1293904 | 1.60 |
ENST00000309212.6 ENST00000342753.4 ENST00000445648.2 |
MXRA8 |
matrix-remodelling associated 8 |
chr14_+_104095514 | 1.59 |
ENST00000348520.6 ENST00000380038.3 ENST00000389744.4 ENST00000557575.1 ENST00000553286.1 ENST00000347839.6 ENST00000555836.1 ENST00000334553.6 ENST00000246489.7 ENST00000557450.1 ENST00000452929.2 ENST00000554280.1 ENST00000445352.4 |
KLC1 |
kinesin light chain 1 |
chr1_-_201476274 | 1.56 |
ENST00000340006.2 |
CSRP1 |
cysteine and glycine-rich protein 1 |
chr14_+_74003818 | 1.53 |
ENST00000311148.4 |
ACOT1 |
acyl-CoA thioesterase 1 |
chr1_-_16482554 | 1.50 |
ENST00000358432.5 |
EPHA2 |
EPH receptor A2 |
chr11_-_119187826 | 1.49 |
ENST00000264036.4 |
MCAM |
melanoma cell adhesion molecule |
chr2_+_5832799 | 1.49 |
ENST00000322002.3 |
SOX11 |
SRY (sex determining region Y)-box 11 |
chr4_+_124317940 | 1.49 |
ENST00000505319.1 ENST00000339241.1 |
SPRY1 |
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
chr11_-_2160180 | 1.46 |
ENST00000381406.4 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr2_+_241375069 | 1.43 |
ENST00000264039.2 |
GPC1 |
glypican 1 |
chrX_-_10645773 | 1.41 |
ENST00000453318.2 |
MID1 |
midline 1 (Opitz/BBB syndrome) |
chr5_-_139943830 | 1.40 |
ENST00000412920.3 ENST00000511201.2 ENST00000356738.2 ENST00000354402.5 ENST00000358580.5 ENST00000508496.2 |
APBB3 |
amyloid beta (A4) precursor protein-binding, family B, member 3 |
chr1_+_66797687 | 1.39 |
ENST00000371045.5 ENST00000531025.1 ENST00000526197.1 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
chr9_-_129885010 | 1.33 |
ENST00000373425.3 |
ANGPTL2 |
angiopoietin-like 2 |
chr11_-_89223883 | 1.32 |
ENST00000528341.1 |
NOX4 |
NADPH oxidase 4 |
chr3_-_48130707 | 1.29 |
ENST00000360240.6 ENST00000383737.4 |
MAP4 |
microtubule-associated protein 4 |
chr22_-_36357671 | 1.27 |
ENST00000408983.2 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr13_-_49018789 | 1.27 |
ENST00000378434.4 |
LPAR6 |
lysophosphatidic acid receptor 6 |
chr3_+_10068095 | 1.26 |
ENST00000287647.3 ENST00000383807.1 ENST00000383806.1 ENST00000419585.1 |
FANCD2 |
Fanconi anemia, complementation group D2 |
chr9_-_129884902 | 1.25 |
ENST00000373417.1 |
ANGPTL2 |
angiopoietin-like 2 |
chr4_+_668348 | 1.22 |
ENST00000511290.1 |
MYL5 |
myosin, light chain 5, regulatory |
chr5_+_140864649 | 1.20 |
ENST00000306593.1 |
PCDHGC4 |
protocadherin gamma subfamily C, 4 |
chr9_-_113761720 | 1.19 |
ENST00000541779.1 ENST00000374430.2 |
LPAR1 |
lysophosphatidic acid receptor 1 |
chr6_-_46293378 | 1.17 |
ENST00000330430.6 |
RCAN2 |
regulator of calcineurin 2 |
chr1_+_163039143 | 1.17 |
ENST00000531057.1 ENST00000527809.1 ENST00000367908.4 |
RGS4 |
regulator of G-protein signaling 4 |
chr10_-_3827417 | 1.16 |
ENST00000497571.1 ENST00000542957.1 |
KLF6 |
Kruppel-like factor 6 |
chr8_-_119124045 | 1.16 |
ENST00000378204.2 |
EXT1 |
exostosin glycosyltransferase 1 |
chr19_-_48614033 | 1.15 |
ENST00000354276.3 |
PLA2G4C |
phospholipase A2, group IVC (cytosolic, calcium-independent) |
chr15_-_30113676 | 1.12 |
ENST00000400011.2 |
TJP1 |
tight junction protein 1 |
chr19_-_19051993 | 1.11 |
ENST00000594794.1 ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3 |
homer homolog 3 (Drosophila) |
chr19_-_48614063 | 1.11 |
ENST00000599921.1 ENST00000599111.1 |
PLA2G4C |
phospholipase A2, group IVC (cytosolic, calcium-independent) |
chr7_-_142247606 | 1.10 |
ENST00000390361.3 |
TRBV7-3 |
T cell receptor beta variable 7-3 |
chr8_-_125740514 | 1.08 |
ENST00000325064.5 ENST00000518547.1 |
MTSS1 |
metastasis suppressor 1 |
chr2_+_54785485 | 1.08 |
ENST00000333896.5 |
SPTBN1 |
spectrin, beta, non-erythrocytic 1 |
chr14_-_103523745 | 1.05 |
ENST00000361246.2 |
CDC42BPB |
CDC42 binding protein kinase beta (DMPK-like) |
chr3_-_119182523 | 1.04 |
ENST00000319172.5 |
TMEM39A |
transmembrane protein 39A |
chrX_+_48432892 | 1.03 |
ENST00000376759.3 ENST00000430348.2 |
RBM3 |
RNA binding motif (RNP1, RRM) protein 3 |
chr11_-_8832182 | 1.02 |
ENST00000527510.1 ENST00000528527.1 ENST00000528523.1 ENST00000313726.6 |
ST5 |
suppression of tumorigenicity 5 |
chr6_-_116575226 | 1.01 |
ENST00000420283.1 |
TSPYL4 |
TSPY-like 4 |
chr1_+_151030234 | 1.00 |
ENST00000368921.3 |
MLLT11 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11 |
chr14_+_96722152 | 1.00 |
ENST00000216629.6 |
BDKRB1 |
bradykinin receptor B1 |
chr12_+_6833237 | 0.99 |
ENST00000229251.3 ENST00000539735.1 ENST00000538410.1 |
COPS7A |
COP9 signalosome subunit 7A |
chr18_+_3262415 | 0.98 |
ENST00000581193.1 ENST00000400175.5 |
MYL12B |
myosin, light chain 12B, regulatory |
chr17_+_75084717 | 0.97 |
ENST00000561721.2 ENST00000589827.1 ENST00000392476.2 |
SEC14L1 |
SEC14-like 1 (S. cerevisiae) |
chr8_-_13372395 | 0.97 |
ENST00000276297.4 ENST00000511869.1 |
DLC1 |
deleted in liver cancer 1 |
chr12_+_56552128 | 0.95 |
ENST00000548580.1 ENST00000293422.5 ENST00000348108.4 ENST00000549017.1 ENST00000549566.1 ENST00000536128.1 ENST00000547649.1 ENST00000547408.1 ENST00000551589.1 ENST00000549392.1 ENST00000548400.1 ENST00000548293.1 |
MYL6 |
myosin, light chain 6, alkali, smooth muscle and non-muscle |
chr2_-_98280383 | 0.94 |
ENST00000289228.5 |
ACTR1B |
ARP1 actin-related protein 1 homolog B, centractin beta (yeast) |
chr8_-_82754427 | 0.94 |
ENST00000353788.4 ENST00000520618.1 ENST00000518183.1 ENST00000396330.2 ENST00000519119.1 ENST00000345957.4 |
SNX16 |
sorting nexin 16 |
chrX_-_92928557 | 0.93 |
ENST00000373079.3 ENST00000475430.2 |
NAP1L3 |
nucleosome assembly protein 1-like 3 |
chr3_-_48130314 | 0.93 |
ENST00000439356.1 ENST00000395734.3 ENST00000426837.2 |
MAP4 |
microtubule-associated protein 4 |
chr18_+_3262954 | 0.92 |
ENST00000584539.1 |
MYL12B |
myosin, light chain 12B, regulatory |
chrX_-_77150985 | 0.91 |
ENST00000358075.6 |
MAGT1 |
magnesium transporter 1 |
chr20_+_43343886 | 0.90 |
ENST00000190983.4 |
WISP2 |
WNT1 inducible signaling pathway protein 2 |
chr2_+_242255297 | 0.90 |
ENST00000401990.1 ENST00000407971.1 ENST00000436795.1 ENST00000411484.1 ENST00000434955.1 ENST00000402092.2 ENST00000441533.1 ENST00000443492.1 ENST00000437066.1 ENST00000429791.1 |
SEPT2 |
septin 2 |
chr17_+_41476327 | 0.90 |
ENST00000320033.4 |
ARL4D |
ADP-ribosylation factor-like 4D |
chr1_-_242162375 | 0.89 |
ENST00000357246.3 |
MAP1LC3C |
microtubule-associated protein 1 light chain 3 gamma |
chr22_-_38713428 | 0.87 |
ENST00000403904.1 ENST00000405675.3 |
CSNK1E |
casein kinase 1, epsilon |
chr22_-_38669030 | 0.87 |
ENST00000361906.3 |
TMEM184B |
transmembrane protein 184B |
chr4_+_667686 | 0.87 |
ENST00000505477.1 |
MYL5 |
myosin, light chain 5, regulatory |
chr16_-_4588469 | 0.86 |
ENST00000588381.1 ENST00000563332.2 |
CDIP1 |
cell death-inducing p53 target 1 |
chr8_-_21966893 | 0.85 |
ENST00000522405.1 ENST00000522379.1 ENST00000309188.6 ENST00000521807.2 |
NUDT18 |
nudix (nucleoside diphosphate linked moiety X)-type motif 18 |
chr22_-_38713394 | 0.84 |
ENST00000396832.1 ENST00000413574.2 |
CSNK1E |
casein kinase 1, epsilon |
chr7_+_22766766 | 0.83 |
ENST00000426291.1 ENST00000401651.1 ENST00000258743.5 ENST00000420258.2 ENST00000407492.1 ENST00000401630.3 ENST00000406575.1 |
IL6 |
interleukin 6 (interferon, beta 2) |
chr18_+_76829385 | 0.82 |
ENST00000426216.2 ENST00000307671.7 ENST00000586672.1 ENST00000586722.1 |
ATP9B |
ATPase, class II, type 9B |
chr11_-_75201791 | 0.82 |
ENST00000529721.1 |
GDPD5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
chr4_-_156298028 | 0.81 |
ENST00000433024.1 ENST00000379248.2 |
MAP9 |
microtubule-associated protein 9 |
chr4_-_111558135 | 0.81 |
ENST00000394598.2 ENST00000394595.3 |
PITX2 |
paired-like homeodomain 2 |
chr7_+_35840542 | 0.80 |
ENST00000435235.1 ENST00000399034.2 ENST00000350320.6 ENST00000469679.2 |
SEPT7 |
septin 7 |
chr14_+_77228532 | 0.80 |
ENST00000167106.4 ENST00000554237.1 |
VASH1 |
vasohibin 1 |
chr7_+_39663061 | 0.79 |
ENST00000005257.2 |
RALA |
v-ral simian leukemia viral oncogene homolog A (ras related) |
chr14_-_93651186 | 0.79 |
ENST00000556883.1 ENST00000298894.4 |
MOAP1 |
modulator of apoptosis 1 |
chr5_-_133304473 | 0.79 |
ENST00000231512.3 |
C5orf15 |
chromosome 5 open reading frame 15 |
chr3_-_52001448 | 0.79 |
ENST00000461554.1 ENST00000395013.3 ENST00000428823.2 ENST00000483411.1 ENST00000461544.1 ENST00000355852.2 |
PCBP4 |
poly(rC) binding protein 4 |
chr11_-_1593150 | 0.77 |
ENST00000397374.3 |
DUSP8 |
dual specificity phosphatase 8 |
chr15_+_44084040 | 0.76 |
ENST00000249786.4 |
SERF2 |
small EDRK-rich factor 2 |
chr19_+_17666403 | 0.76 |
ENST00000252599.4 |
COLGALT1 |
collagen beta(1-O)galactosyltransferase 1 |
chr12_-_6772303 | 0.76 |
ENST00000396807.4 ENST00000446105.2 ENST00000341550.4 |
ING4 |
inhibitor of growth family, member 4 |
chr3_+_8543533 | 0.75 |
ENST00000454244.1 |
LMCD1 |
LIM and cysteine-rich domains 1 |
chr14_+_88851874 | 0.75 |
ENST00000393545.4 ENST00000356583.5 ENST00000555401.1 ENST00000553885.1 |
SPATA7 |
spermatogenesis associated 7 |
chr10_+_134351319 | 0.74 |
ENST00000368594.3 ENST00000368593.3 |
INPP5A |
inositol polyphosphate-5-phosphatase, 40kDa |
chr16_+_2564254 | 0.74 |
ENST00000565223.1 |
ATP6V0C |
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c |
chr12_+_58138800 | 0.74 |
ENST00000547992.1 ENST00000552816.1 ENST00000547472.1 |
TSPAN31 |
tetraspanin 31 |
chr12_+_6833437 | 0.74 |
ENST00000534947.1 ENST00000541866.1 ENST00000534877.1 ENST00000538753.1 |
COPS7A |
COP9 signalosome subunit 7A |
chr7_+_100273736 | 0.72 |
ENST00000412215.1 ENST00000393924.1 |
GNB2 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 |
chr15_+_68871569 | 0.72 |
ENST00000566799.1 |
CORO2B |
coronin, actin binding protein, 2B |
chr4_-_156297949 | 0.72 |
ENST00000515654.1 |
MAP9 |
microtubule-associated protein 9 |
chr9_+_34990219 | 0.71 |
ENST00000541010.1 ENST00000454002.2 ENST00000545841.1 |
DNAJB5 |
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr1_+_17866290 | 0.70 |
ENST00000361221.3 ENST00000452522.1 ENST00000434513.1 |
ARHGEF10L |
Rho guanine nucleotide exchange factor (GEF) 10-like |
chr11_-_14993819 | 0.70 |
ENST00000396372.2 ENST00000361010.3 ENST00000359642.3 ENST00000331587.4 |
CALCA |
calcitonin-related polypeptide alpha |
chr2_+_242255275 | 0.68 |
ENST00000391971.2 |
SEPT2 |
septin 2 |
chr7_+_35840819 | 0.68 |
ENST00000399035.3 |
SEPT7 |
septin 7 |
chr7_-_37956409 | 0.67 |
ENST00000436072.2 |
SFRP4 |
secreted frizzled-related protein 4 |
chrX_+_49832231 | 0.67 |
ENST00000376108.3 |
CLCN5 |
chloride channel, voltage-sensitive 5 |
chr5_-_95297534 | 0.66 |
ENST00000513343.1 ENST00000431061.2 |
ELL2 |
elongation factor, RNA polymerase II, 2 |
chr1_+_145293114 | 0.65 |
ENST00000369338.1 |
NBPF10 |
neuroblastoma breakpoint family, member 10 |
chrX_-_153602991 | 0.64 |
ENST00000369850.3 ENST00000422373.1 |
FLNA |
filamin A, alpha |
chr11_+_818902 | 0.63 |
ENST00000336615.4 |
PNPLA2 |
patatin-like phospholipase domain containing 2 |
chr7_-_45128472 | 0.63 |
ENST00000490531.2 |
NACAD |
NAC alpha domain containing |
chr2_-_242255117 | 0.62 |
ENST00000420451.1 ENST00000417540.1 ENST00000310931.4 |
HDLBP |
high density lipoprotein binding protein |
chr4_-_156298087 | 0.62 |
ENST00000311277.4 |
MAP9 |
microtubule-associated protein 9 |
chr12_+_58138664 | 0.61 |
ENST00000257910.3 |
TSPAN31 |
tetraspanin 31 |
chr20_+_43343517 | 0.61 |
ENST00000372865.4 |
WISP2 |
WNT1 inducible signaling pathway protein 2 |
chr11_+_57529234 | 0.60 |
ENST00000360682.6 ENST00000361796.4 ENST00000529526.1 ENST00000426142.2 ENST00000399050.4 ENST00000361391.6 ENST00000361332.4 ENST00000532463.1 ENST00000529986.1 ENST00000358694.6 ENST00000532787.1 ENST00000533667.1 ENST00000532649.1 ENST00000528621.1 ENST00000530748.1 ENST00000428599.2 ENST00000527467.1 ENST00000528232.1 ENST00000531014.1 ENST00000526772.1 ENST00000529873.1 ENST00000525902.1 ENST00000532844.1 ENST00000526357.1 ENST00000530094.1 ENST00000415361.2 ENST00000532245.1 ENST00000534579.1 ENST00000526938.1 |
CTNND1 |
catenin (cadherin-associated protein), delta 1 |
chr19_+_39214797 | 0.60 |
ENST00000440400.1 |
ACTN4 |
actinin, alpha 4 |
chr1_+_36023370 | 0.60 |
ENST00000356090.4 ENST00000373243.2 |
NCDN |
neurochondrin |
chr2_-_207082748 | 0.60 |
ENST00000407325.2 ENST00000411719.1 |
GPR1 |
G protein-coupled receptor 1 |
chr15_+_68871308 | 0.60 |
ENST00000261861.5 |
CORO2B |
coronin, actin binding protein, 2B |
chr9_+_34989638 | 0.60 |
ENST00000453597.3 ENST00000335998.3 ENST00000312316.5 |
DNAJB5 |
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr18_+_3412005 | 0.59 |
ENST00000401449.1 |
TGIF1 |
TGFB-induced factor homeobox 1 |
chrX_-_68385354 | 0.59 |
ENST00000361478.1 |
PJA1 |
praja ring finger 1, E3 ubiquitin protein ligase |
chr16_+_31044413 | 0.59 |
ENST00000394998.1 |
STX4 |
syntaxin 4 |
chr12_+_54378923 | 0.59 |
ENST00000303460.4 |
HOXC10 |
homeobox C10 |
chr17_-_80231557 | 0.58 |
ENST00000392334.2 ENST00000314028.6 |
CSNK1D |
casein kinase 1, delta |
chr17_-_7155274 | 0.58 |
ENST00000318988.6 ENST00000575783.1 ENST00000573600.1 |
CTDNEP1 |
CTD nuclear envelope phosphatase 1 |
chrX_-_68385274 | 0.58 |
ENST00000374584.3 ENST00000590146.1 |
PJA1 |
praja ring finger 1, E3 ubiquitin protein ligase |
chr2_-_89459813 | 0.57 |
ENST00000390256.2 |
IGKV6-21 |
immunoglobulin kappa variable 6-21 (non-functional) |
chr8_-_141810634 | 0.56 |
ENST00000521986.1 ENST00000523539.1 ENST00000538769.1 |
PTK2 |
protein tyrosine kinase 2 |
chr16_-_5083917 | 0.56 |
ENST00000312251.3 ENST00000381955.3 |
NAGPA |
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase |
chr22_+_51176624 | 0.56 |
ENST00000216139.5 ENST00000529621.1 |
ACR |
acrosin |
chr2_+_10183651 | 0.56 |
ENST00000305883.1 |
KLF11 |
Kruppel-like factor 11 |
chr19_-_59066452 | 0.56 |
ENST00000312547.2 |
CHMP2A |
charged multivesicular body protein 2A |
chr1_-_230850043 | 0.55 |
ENST00000366667.4 |
AGT |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
chr19_-_49622348 | 0.55 |
ENST00000408991.2 |
C19orf73 |
chromosome 19 open reading frame 73 |
chr20_+_8112824 | 0.55 |
ENST00000378641.3 |
PLCB1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.9 | 5.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.9 | 2.7 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.9 | 18.5 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.6 | 3.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.6 | 1.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.5 | 3.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 1.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 5.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 1.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 0.3 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.3 | 0.8 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.3 | 0.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 1.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 9.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 2.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 2.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 4.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 9.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.2 | 2.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 8.0 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 2.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 13.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 3.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 1.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 2.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 3.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 5.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 2.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.4 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.1 | 0.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 1.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.4 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 0.6 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 2.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 1.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 2.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 8.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 1.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 2.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 7.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.2 | GO:0004040 | amidase activity(GO:0004040) fucose binding(GO:0042806) |
0.1 | 1.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.9 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 1.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.6 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 2.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.2 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.2 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.1 | 1.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.0 | 1.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.0 | 1.9 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 6.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.3 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.0 | 0.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 1.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 1.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.7 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.7 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 1.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.0 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.0 | 0.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.0 | 0.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.1 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.0 | 0.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 4.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.8 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 1.8 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 1.1 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 2.2 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.4 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
1.3 | 3.8 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.8 | 3.8 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.7 | 6.7 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.7 | 2.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.6 | 1.8 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.3 | 1.7 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.3 | 1.2 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.3 | 2.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 2.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 0.8 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.2 | 5.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 2.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 1.8 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.2 | 1.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.6 | GO:0004040 | amidase activity(GO:0004040) fucose binding(GO:0042806) |
0.2 | 1.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 0.2 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.2 | 0.7 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.2 | 7.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.5 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.2 | 1.0 | GO:0039552 | RIG-I binding(GO:0039552) |
0.2 | 0.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 2.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 8.2 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.2 | 0.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 0.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.4 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.1 | 0.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 1.3 | GO:1990380 | Lys63-specific deubiquitinase activity(GO:0061578) Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 11.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 2.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 10.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 4.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 4.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.6 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 8.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.1 | GO:0051430 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 1.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 1.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 1.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.7 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.4 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 0.2 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 1.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 6.7 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 1.8 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 1.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.0 | 3.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.8 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 1.9 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 1.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 1.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 6.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.5 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 1.3 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.8 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 5.0 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 3.0 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 1.0 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 1.5 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.9 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
1.2 | 3.7 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.9 | 3.7 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.7 | 4.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 1.3 | GO:0035276 | aldehyde oxidase activity(GO:0004031) ethanol binding(GO:0035276) |
0.3 | 2.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 0.9 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 0.6 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 1.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.6 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.1 | 2.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 1.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 1.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 2.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.6 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.3 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 2.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 0.4 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.1 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.1 | GO:0047023 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) androsterone dehydrogenase activity(GO:0047023) indanol dehydrogenase activity(GO:0047718) |
0.0 | 0.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 1.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 1.3 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 0.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 1.1 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 8.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 3.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 4.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 11.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 6.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 8.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 4.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 2.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 1.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 1.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 5.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 2.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 1.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 1.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 4.6 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 1.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 1.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 4.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 2.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 1.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 1.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 1.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.0 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
1.2 | 9.6 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
1.2 | 3.5 | GO:0060460 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
1.1 | 3.3 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.1 | 3.2 | GO:0061386 | closure of optic fissure(GO:0061386) |
1.0 | 5.8 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
1.0 | 8.6 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.9 | 3.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.9 | 5.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.8 | 2.5 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.8 | 8.1 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.6 | 11.8 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.6 | 1.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.5 | 1.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.5 | 1.4 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.4 | 4.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 15.6 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.4 | 1.9 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.4 | 1.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.4 | 0.7 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.3 | 1.0 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.3 | 1.0 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.3 | 1.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 5.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.3 | 0.9 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.3 | 9.0 | GO:0042730 | fibrinolysis(GO:0042730) |
0.3 | 1.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.3 | 0.8 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.3 | 0.8 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.2 | 1.7 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.2 | 2.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 0.7 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.2 | 0.7 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.2 | 2.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 1.3 | GO:0051012 | microtubule sliding(GO:0051012) |
0.2 | 2.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 1.1 | GO:2000035 | positive regulation of somatic stem cell population maintenance(GO:1904674) regulation of stem cell division(GO:2000035) |
0.2 | 0.6 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.2 | 1.9 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 0.6 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.2 | 4.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 1.6 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 0.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 0.6 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.2 | 2.6 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 1.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 0.7 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.2 | 0.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 1.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 2.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.5 | GO:0046066 | dGDP metabolic process(GO:0046066) |
0.1 | 3.8 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 2.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 1.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.4 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.1 | 1.3 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 2.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.4 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.1 | 0.4 | GO:1901899 | dense core granule biogenesis(GO:0061110) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 1.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 2.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 1.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 1.7 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.6 | GO:0044856 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.1 | 0.5 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 2.3 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.1 | 0.7 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 1.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 2.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 1.5 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 1.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 1.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.3 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.3 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.3 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.1 | 0.3 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.1 | 0.2 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.1 | 1.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.8 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.1 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.1 | 0.3 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.9 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 0.9 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 1.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 5.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 1.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.9 | GO:0051412 | response to corticosterone(GO:0051412) |
0.1 | 0.3 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.2 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 0.5 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.1 | 0.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.2 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.1 | 1.7 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.7 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 4.5 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.1 | 0.2 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.1 | 0.5 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.5 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.0 | 0.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.0 | 0.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.0 | 2.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.4 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.0 | 0.7 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.9 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.3 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.3 | GO:0033523 | nucleosome positioning(GO:0016584) histone H2B ubiquitination(GO:0033523) |
0.0 | 0.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.0 | 0.4 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.0 | 0.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.0 | 0.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.0 | 0.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.5 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 1.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.0 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.0 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.3 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 1.1 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.1 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 2.7 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.8 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
0.0 | 0.5 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.0 | 2.9 | GO:0006024 | aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 | 3.5 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.3 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.1 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.4 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.6 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.1 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.0 | 0.2 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.6 | GO:0032402 | melanosome transport(GO:0032402) |
0.0 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.7 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.1 | GO:0046959 | habituation(GO:0046959) determination of affect(GO:0050894) |
0.0 | 1.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 1.3 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.8 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.4 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.1 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.0 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.3 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 4.5 | GO:0007507 | heart development(GO:0007507) |
0.0 | 0.2 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.4 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.8 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 2.1 | GO:0030323 | respiratory tube development(GO:0030323) |
0.0 | 0.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 1.7 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.8 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.0 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.0 | 0.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 15.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 8.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 8.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 6.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 3.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 5.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 2.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 3.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 4.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 3.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 2.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 2.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 2.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 1.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 1.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 1.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.9 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 1.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.9 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.4 | 3.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 2.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 2.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 4.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 1.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 6.6 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 1.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 7.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.0 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 2.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 2.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.3 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.4 | GO:0032059 | bleb(GO:0032059) |
0.0 | 1.0 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 2.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.9 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 1.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 1.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.5 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 6.6 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
1.1 | 3.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.6 | 8.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.6 | 8.2 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.5 | 2.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.4 | 1.8 | GO:0031673 | H zone(GO:0031673) |
0.4 | 6.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 0.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.3 | 2.1 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.2 | 3.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 4.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 1.8 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 3.1 | GO:0097227 | sperm annulus(GO:0097227) |
0.2 | 0.6 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.2 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 7.2 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 2.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 0.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.6 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.4 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.1 | 0.9 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.1 | 2.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 2.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 7.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 1.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 3.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 1.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 1.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 4.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 2.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 3.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.4 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 1.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 1.3 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 3.8 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 1.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 1.0 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 1.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.7 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 0.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 19.3 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 2.6 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.3 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 2.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 1.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 1.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 9.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 1.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 1.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 1.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 1.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 0.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.4 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 2.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.7 | GO:0036064 | ciliary basal body(GO:0036064) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 3.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 4.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 2.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.9 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 2.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 9.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 8.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 3.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 7.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 8.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 5.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 3.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 5.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 3.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 3.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 2.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 1.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 1.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 2.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 5.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.7 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 1.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.2 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
1.3 | 3.8 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
1.2 | 3.7 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
1.2 | 8.4 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.8 | 3.3 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.8 | 2.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.6 | 0.6 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.5 | 1.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.5 | 1.5 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.4 | 1.7 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.4 | 2.6 | GO:0051012 | microtubule sliding(GO:0051012) |
0.4 | 1.3 | GO:0046066 | dGDP metabolic process(GO:0046066) |
0.4 | 1.3 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.4 | 2.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.4 | 1.1 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.4 | 1.1 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.4 | 1.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 1.0 | GO:0090427 | activation of meiosis(GO:0090427) |
0.3 | 2.7 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 1.9 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 6.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.3 | 1.6 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.3 | 3.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.3 | 2.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.3 | 1.2 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.3 | 1.5 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.3 | 1.4 | GO:0030200 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.3 | 0.8 | GO:0002384 | hepatic immune response(GO:0002384) regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
0.3 | 0.8 | GO:0060577 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
0.2 | 6.5 | GO:0007567 | parturition(GO:0007567) |
0.2 | 1.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 1.5 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.2 | 2.1 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.2 | 0.7 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.2 | 1.6 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 0.7 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.2 | 7.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 1.5 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 1.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 1.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 3.5 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.6 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.2 | 1.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.6 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.2 | 0.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 6.7 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 2.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.2 | 1.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 6.1 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.2 | 1.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 0.5 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.1 | 2.2 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 1.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.7 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.4 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.1 | 2.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.4 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.1 | 0.5 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.4 | GO:1901899 | dense core granule biogenesis(GO:0061110) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 0.4 | GO:0060278 | negative regulation of B cell differentiation(GO:0045578) regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 1.7 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.5 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.1 | 2.5 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.4 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.1 | 1.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 1.4 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 4.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 8.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.6 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.9 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 1.6 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 1.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 1.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.3 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
0.1 | 0.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.5 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 1.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.5 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.7 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 5.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.8 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.1 | GO:0086053 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.1 | 0.7 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.8 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 2.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.6 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.2 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.1 | 0.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.2 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.1 | 0.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.2 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.1 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.5 | GO:0003094 | glomerular filtration(GO:0003094) |
0.1 | 1.0 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.0 | 4.1 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 1.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 1.5 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) asymmetric Golgi ribbon formation(GO:0090164) |
0.0 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.0 | 0.4 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.3 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.0 | 0.6 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.2 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.9 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 1.0 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 1.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 1.6 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.3 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.8 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.5 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 1.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 1.8 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.5 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 3.9 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.5 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.4 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.0 | 0.9 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.0 | 0.4 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 0.2 | GO:0001711 | endodermal cell fate commitment(GO:0001711) nucleosome positioning(GO:0016584) |
0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.2 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 0.2 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 1.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.2 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.0 | 0.5 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 1.6 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 1.0 | GO:0045453 | bone resorption(GO:0045453) |
0.0 | 0.7 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.0 | 1.9 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 0.1 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.0 | 0.2 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.0 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.0 | 5.8 | GO:0007015 | actin filament organization(GO:0007015) |
0.0 | 0.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.3 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.1 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.0 | 1.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.3 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.0 | 4.3 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.0 | 1.5 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
0.0 | 0.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 1.2 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.3 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.3 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
0.0 | 0.0 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 3.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 2.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 2.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 7.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 3.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 1.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 2.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 1.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 18.4 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
1.1 | 9.1 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.6 | 8.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 3.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.4 | 5.2 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 1.5 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.3 | 4.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 4.5 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 2.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 2.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 3.2 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 1.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 4.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 3.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 0.6 | GO:0031673 | H zone(GO:0031673) |
0.1 | 0.8 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 0.8 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 0.6 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.9 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 1.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 9.0 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.3 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.1 | 0.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 2.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 2.5 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.4 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 6.6 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.6 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) lateral loop(GO:0043219) |
0.1 | 1.1 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 2.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 2.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.5 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 6.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 2.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 5.7 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 1.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 1.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.6 | GO:0031082 | BLOC complex(GO:0031082) |
0.0 | 1.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 1.2 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 1.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 3.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 8.9 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 2.2 | GO:0005814 | centriole(GO:0005814) |
0.0 | 9.0 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.4 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 1.3 | GO:0012505 | endomembrane system(GO:0012505) |
0.0 | 0.1 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 0.5 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.4 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.4 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 1.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.2 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 1.0 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.4 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 1.1 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.4 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 17.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 5.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.3 | 5.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 7.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 4.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 2.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 8.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 4.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 1.5 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.1 | 5.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 2.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 1.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 3.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 0.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 5.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.7 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 2.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 1.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.3 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 1.3 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.2 | 3.7 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.7 | 4.6 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.5 | 3.7 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.4 | 1.3 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.4 | 7.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.4 | 1.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.3 | 1.3 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 1.9 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.3 | 2.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 0.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.6 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.2 | 2.4 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.2 | 1.7 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.2 | 0.8 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.1 | 0.4 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 1.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 2.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.7 | GO:0061517 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.1 | 0.5 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 0.9 | GO:1903027 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) regulation of opsonization(GO:1903027) |
0.1 | 0.4 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.3 | GO:0097368 | histone H4-K20 trimethylation(GO:0034773) establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.3 | GO:0002424 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
0.1 | 0.5 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 1.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.7 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.5 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.1 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.4 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 4.9 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 0.4 | GO:0051414 | response to cortisol(GO:0051414) |
0.1 | 0.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.3 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.1 | 1.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.5 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.3 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.1 | GO:0007538 | primary sex determination(GO:0007538) |
0.0 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 2.0 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.0 | 0.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.6 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.1 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.0 | 0.3 | GO:1903944 | negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.0 | 0.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.5 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 0.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.9 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 3.5 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.1 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
0.0 | 0.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 1.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.0 | 2.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.1 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.0 | 1.0 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.0 | 0.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.3 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |